Skip to content
Toggle main navigation
PURPOSE logo
PURPOSE logo
  • Home
  • Events
  • Opportunities
  • News & Publications
  • T90/R90 HEAL Pain Cohort Program
  • Mobile App
  • About
  • Exhibit
  • Affiliate Networks
    • Music4Pain (U24)
    • ENSEMBLE Network (U24)
    • Pain Research Forum (PRF)
    • ForceNET (U24)
    • NeuronS_MATTR (U24)
    • SPINEWORK Network (U24)
    Log in
    Request to Join

    News & Publications

    Do you have news or publications to share with the PURPOSE Network? Submit your news below.

    Submit Your News or Publication
    All
    Acquired Cognitive Impairment
    Acupuncture
    Addiction
    Ageing
    Alcohol Use / Alcohol Use Disorder (AUD)
    Analgesics
    Analgesics, Topical
    Anatomy
    Anesthesia, General
    Anesthesia, Intravenous regional
    Anesthesia, Local
    Anesthesia, Spinal
    Animal Models
    Anxiety
    Arthritis, Rheumatoid
    See all

    Highlighted News

    Results (15)

    Identification and validation of plasma biomarkers for predicting postpartum pain risk using machine learning-integrated proteomics

    Identification and validation of plasma biomarkers for predicting postpartum pain risk using machine learning-integrated proteomics

    Pak J Med Sci. 2026 Oct;42(10):2809-2820. doi: 10.12669/pjms.42.10.20485.ABSTRACTBACKGROUND AND OBJECTIVE: Postpartum pain (PP) remains a significant clinical challenge with poorly understood molecular mechanisms. This study aimed to identify and validate plasma biomarkers for PP through integrated proteomics and machine learning approaches.METHODOLOGY: The study included a discovery cohort of 16
    November 17, 2026
    Exosomal non-coding RNA cross-talk between DRG neurons and spinal microglia in neuropathic pain: mechanistic insights, neuroimmune reprogramming, and therapeutic opportunities

    Exosomal non-coding RNA cross-talk between DRG neurons and spinal microglia in neuropathic pain: mechanistic insights, neuroimmune reprogramming, and therapeutic opportunities

    Front Physiol. 2026 Nov 2;17:1911923. doi: 10.3389/fphys.2026.1911923. eCollection 2026.ABSTRACTNeuropathic pain represents a complex chronic pain state arising from nervous system damage or dysfunction, affecting millions worldwide with significant socioeconomic burden. Recent evidence has illuminated a critical role for extracellular vesicle-mediated communication, particularly exosomal transfer
    November 17, 2026
    Enhanced Endosomal Trafficking Mediated by the Proton-Activated Chloride Channel Underlies Peripheral Sensitization in Neuropathic Pain

    Enhanced Endosomal Trafficking Mediated by the Proton-Activated Chloride Channel Underlies Peripheral Sensitization in Neuropathic Pain

    Research (Wash D C). 2026 Nov 16;9:1475. doi: 10.34133/research.1475. eCollection 2026.ABSTRACTEndosomal trafficking is essential for protein homeostasis, yet its role in peripheral sensitization of neuropathic pain remains unclear. Here, we identify the proton-activated chloride (PAC) channel as a critical regulator of endosomal trafficking in sensory neurons. In the spared nerve injury (SNI) mod
    November 17, 2026
    Electroacupuncture relieves neuropathic pain via modulation of the ferroptosis pathway through GPX4

    Electroacupuncture relieves neuropathic pain via modulation of the ferroptosis pathway through GPX4

    Acupunct Med. 2026 Nov 8:9645284261486883. doi: 10.1177/09645284261486883. Online ahead of print.ABSTRACTOBJECTIVES: Neuropathic pain (NP) is a chronic condition with complex mechanisms and limited treatments. While electroacupuncture (EA) shows promising analgesic effects, its molecular mechanisms remain unclear. This study investigated whether EA modulates ferroptosis to alleviate NP via glutath
    November 9, 2026
    AT-RvD1 liposomes effectively accumulate in spinal cord and reprogram microglia via ANGPTL4-SUCLG1-propionate axis for treating neuropathic pain

    AT-RvD1 liposomes effectively accumulate in spinal cord and reprogram microglia via ANGPTL4-SUCLG1-propionate axis for treating neuropathic pain

    Mater Today Bio. 2026 Oct 5;41:103726. doi: 10.1016/j.mtbio.2026.103726. eCollection 2026 Dec.ABSTRACTNeuropathic pain (NP) remains a major clinical challenge as current medications are ineffective in treating the underlying cause, and the clinical use of these drugs also has adverse reactions such as addiction. Therefore, specialized pro-resolving mediators (SPMs) may represent a promising therap
    October 20, 2026
    Dynamic remodeling of the transcriptional landscape drives Merkel cell specification and mechanosensory differentiation

    Dynamic remodeling of the transcriptional landscape drives Merkel cell specification and mechanosensory differentiation

    Source: Proceedings of the National Academy of Sciences of the United States of AmericaAuthors: Yajun Zhang, Huipu Yuan, Yuyan Jiang, Teng Wang, Chen Rui, Yuanyuan Ding, Tuan Wang, Chaochen Wang, Ying Xiao, Publication Date: Tue, 22 Sep 2026 06:00:00 -0400Proc Natl Acad Sci U S A. 2026 Sep 29;123(39):e2603770123. doi: 10.1073/pnas.2603770123. Epub 2026 Sep 22.ABSTRACTMerkel cells (MCs) are special
    October 16, 2026
    Cyclodextrins in chronic pain: Membrane cholesterol remodeling and neuroimmune signaling

    Cyclodextrins in chronic pain: Membrane cholesterol remodeling and neuroimmune signaling

    Biomed Pharmacother. 2026 Aug 27;203:119889. doi: 10.1016/j.biopha.2026.119889. Online ahead of print.ABSTRACTBACKGROUND: Chronic pain remains challenging to treat, with current therapies offering incomplete relief and significant side effects. This narrative review examines cyclodextrins (CDs) beyond their conventional excipient role, focusing on their emerging function as membrane-active modulat
    August 28, 2026
    Dorsal horn DCC amplification loop induced by endplate osteoclasts generates chronic nociplastic low back pain in male mice

    Dorsal horn DCC amplification loop induced by endplate osteoclasts generates chronic nociplastic low back pain in male mice

    Nat Commun. 2026 Jul 14. doi: 10.1038/s41467-026-75423-9. Online ahead of print.ABSTRACTSpine degeneration is associated with low back pain (LBP), a major cause of disability and functional decline. However, effective therapies for non-specific LBP remain limited because its underlying mechanisms are poorly understood. Here, we show that spine degeneration induces netrin-1 secretion in porous endp
    July 17, 2026
    The Role of the Mitochondrial Permeability Transition Pore in Chronic Pain

    The Role of the Mitochondrial Permeability Transition Pore in Chronic Pain

    Curr Neuropharmacol. 2026 Jul 10. doi: 10.2174/011570159X487795260629095134. Online ahead of print.ABSTRACTThe mitochondrial Permeability Transition Pore (mPTP) has been implicated in cell death, energy failure, and oxidative stress. Emerging evidence suggests that mPTP may also contribute to the development and maintenance of chronic pain, although evidence remains limited and the underlying mech
    July 16, 2026
    Expression of circulating GRP78 and gp96, endoplasmic reticulum stress-related proteins, in menstrual and bladder pain sensitivity

    Expression of circulating GRP78 and gp96, endoplasmic reticulum stress-related proteins, in menstrual and bladder pain sensitivity

    Sci Rep. 2026 Jun 30. doi: 10.1038/s41598-026-58824-0. Online ahead of print.ABSTRACTDysmenorrhea is often linked to uterine inflammation, but the additional factors and pathways that contribute to its pathophysiology remain poorly understood. Given growing evidence linking endoplasmic reticulum (ER) stress to inflammation and pain sensitization, we examined circulating ER stress-associated heat s
    June 30, 2026
    Bergenin attenuates neuropathic pain by modulation of TRPV1/CGRP signalling and neuro-inflammatory mechanisms

    Bergenin attenuates neuropathic pain by modulation of TRPV1/CGRP signalling and neuro-inflammatory mechanisms

    Mol Biol Rep. 2026 Jun 18;53(1):937. doi: 10.1007/s11033-026-12098-x.ABSTRACTBACKGROUND AND PURPOSE: Neuropathic pain is a chronic and disabling condition characterized by persistent sensory hypersensitivity and inadequate treatment options. Neuroinflammation and TRPV1/CGRP-driven nociceptive pathways are critical contributors to its pathogenesis. Bergenin, a naturally occurring C-glucoside with e
    June 20, 2026
    Decoding visceral pain: Molecular pathways and translational targets in gaseous signalling and pharmacology

    Decoding visceral pain: Molecular pathways and translational targets in gaseous signalling and pharmacology

    Br J Pharmacol. 2026 Jun 7. doi: 10.1111/bph.70526. Online ahead of print.ABSTRACTVisceral pain, a hallmark of many gastrointestinal (GI) disorders, remains a persistent clinical challenge due to its multifactorial pathophysiology and limited treatment options. Recent advances highlight the role of endogenous gaseous signalling molecules, hydrogen sulphide (H2S), nitric oxide (NO) and carbon monox
    June 9, 2026
    Nerve Growth Factor: A Multifaceted Regulator of Pain, Inflammation, and Tissue Remodeling in Bone and Joint Disorders

    Nerve Growth Factor: A Multifaceted Regulator of Pain, Inflammation, and Tissue Remodeling in Bone and Joint Disorders

    Cell Biochem Funct. 2026 Jun;44(6):e70237. doi: 10.1002/cbf.70237.ABSTRACTAs an essential member of the neurotrophic factor family, nerve growth factor (NGF) plays multifaceted regulatory roles in the pathological processes of bone and joint diseases through its dual signaling mechanisms involving high-affinity receptor TrkA and low-affinity receptor p75NTR. This review systematically examines the
    June 8, 2026
    CTRP3 alleviates neuropathic pain by improving mitochondrial biogenesis and mitochondrial unfolded protein response via spinal SIRT1 in rats

    CTRP3 alleviates neuropathic pain by improving mitochondrial biogenesis and mitochondrial unfolded protein response via spinal SIRT1 in rats

    Int J Mol Med. 2026 Jul;58(1):197. doi: 10.3892/ijmm.2026.5868. Epub 2026 May 22.ABSTRACTNeuropathic pain arises from an intricate network of interconnected pathophysiological mechanisms, yet the arsenal of effective therapeutic strategies remains frustratingly limited. Accumulating evidence has linked mitochondrial dysfunction to the progression of neuropathic pain. C1q‑tumor necrosis factor‑rela
    May 22, 2026
    JNK inhibition suppresses microglial NLRP3 activation and oxidative stress but unexpectedly worsens pain in diabetic neuropathy: insights from a combined in vitro and in vivo pharmacological study

    JNK inhibition suppresses microglial NLRP3 activation and oxidative stress but unexpectedly worsens pain in diabetic neuropathy: insights from a combined in vitro and in vivo pharmacological study

    Neurochem Int. 2026 May 4:106167. doi: 10.1016/j.neuint.2026.106167. Online ahead of print.ABSTRACTDiabetic neuropathy (DN) is driven by neuroinflammation and oxidative stress, with c-Jun N-terminal kinase (JNK) as a key mediator; however, the effects of JNK inhibition on neuropathic pain remain unclear. Therefore, we investigated the therapeutic potential of the JNK inhibitor SP600125 in a type 2
    May 7, 2026
    Contact
    Neurovations Education
    [email protected]

    United States

    PURPOSE@PainResearchers.com
    707-260-0848
    Links
    • NIH HEAL Initiative
    • Research in Pain Management